Viva L-Arginine 500 mg Capsules
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| acide (2S)-2-amino-5-{[amino(imino)méthyl]amino}pentanoïque | 500 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Zea mays, Gélatine, Dioxyde de silicium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 4 Capsule ; maximum: 12 Capsule | 3 Tous les jours |
Uses authorised in Canada
l
The medicinal ingredient in this product helps to support healthy cardiovascular function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have human herpes virus. Consult a health care practitioner prior to use if you have sickle cell anemia. Consult a health care practitioner prior to use if you are taking antihypertensives, cyclosporine, estrogens, birth control medications, medoxyprogesterone, norethindrone, nitrates, potassium-increasing drugs, sildenafil, xylitol, and/or aminophyllins. Discontinue use if you have gout . Discontinue use if you have decreased platelet count. Discontinue use if you have elevated blood-urea-nitrogen, serum creatine and creatinine. Discontinue use if you have delayed menses.
- Contre-indications
Do not use if you have asthma. Do not use if you are pregant or breastfeeding.
Product record
- Other names
- Vita L-Arginine 500 mg Capsules
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80001281
- Status
- Active licence
- Licence date
- 24 January 2006
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80001281
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Viva L-Arginine 500 mg Capsules (Viva Pharmaceutical Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80001281-viva-l-arginine-500-mg-capsules, updated 24 January 2006.